- Home
- SPH vs AMPH Comparison
SPH vs AMPH Comparison
Compare SPH & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPH
- AMPH
- Stock Information
- Founded
- SPH 1945
- AMPH 1996
- Country
- SPH United States
- AMPH United States
- Employees
- SPH N/A
- AMPH N/A
- Industry
- SPH Other Specialty Stores
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- SPH Consumer Discretionary
- AMPH Health Care
- Exchange
- SPH Nasdaq
- AMPH Nasdaq
- Market Cap
- SPH 1.2B
- AMPH 1.1B
- IPO Year
- SPH 1996
- AMPH 2014
- Fundamental
- Price
- SPH $18.58
- AMPH $28.02
- Analyst Decision
- SPH
- AMPH Buy
- Analyst Count
- SPH 0
- AMPH 6
- Target Price
- SPH N/A
- AMPH $35.50
- AVG Volume (30 Days)
- SPH 90.4K
- AMPH 424.7K
- Earning Date
- SPH 08-07-2025
- AMPH 11-05-2025
- Dividend Yield
- SPH 6.98%
- AMPH N/A
- EPS Growth
- SPH N/A
- AMPH N/A
- EPS
- SPH 1.49
- AMPH 2.68
- Revenue
- SPH $1,429,783,000.00
- AMPH $722,679,000.00
- Revenue This Year
- SPH $10.99
- AMPH $1.06
- Revenue Next Year
- SPH N/A
- AMPH $7.06
- P/E Ratio
- SPH $12.51
- AMPH $10.70
- Revenue Growth
- SPH 6.29
- AMPH 1.37
- 52 Week Low
- SPH $16.92
- AMPH $20.39
- 52 Week High
- SPH $22.24
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- SPH 51.49
- AMPH 48.14
- Support Level
- SPH $18.10
- AMPH $28.34
- Resistance Level
- SPH $18.59
- AMPH $29.43
- Average True Range (ATR)
- SPH 0.31
- AMPH 0.86
- MACD
- SPH 0.00
- AMPH -0.48
- Stochastic Oscillator
- SPH 63.62
- AMPH 1.72
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.